ICAM1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Except for the differences in ICAM-1 expression, serum-mediated effects on EC surface molecules appeared to be comparable between PCS and PCS/CFS patients, unlike the EC secretion profile which deviated profoundly.